Comparative Study Between Platelet Rich Plasma and Steroid Injection in Trigger Finger Treatment

The goal of this clinical trial is to learn if platelet rich plasma works to treat early stage trigger finger in adults. It will also learn about the safety platelet rich plasma. The main questions it aims to answer are: Does platelet rich plasma lower the pain associated with trigger finger of participants? Does it improve the hand grip strength and Q DASH score of participants? Researchers will compare platelet rich plasma to Depo-Medrol steroid (a known standard of care for early stage trigger finger) to see if platelet rich plasma works to treat early trigger finger. Participants will: Take platelet rich plasma or a depo-medrol steroid intralesional injection at recruitment into the intervention Visit the clinic once every 4 weeks for checkups and parameter measurements. Investigator will will keep a record of participants progress in symptom remission

NCT Number	NCT06532318
Lead Sponsor	Obafemi Awolowo University Teaching Hospital
Conditions	Trigger Finger Disorder
Enrollment	40 participants
Start Date	2024-07-24
Primary Completion	2024-12-23 (estimated)
Study Completion	2025-06-23 (estimated)
Updated on ClinicalTrials.gov	2024-08-01